🔎 Trials Near Me

Hem › KOL › Missouri

Kliniska studier för KOL i Missouri

7 studier för KOL söker deltagare vid platser i Missouri.

Städer i Missouri

Officiell studietext (engelska)

Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype

  • University of Missouri Health Care - Children's Hospital- Site Number : 8400150, Columbia
  • Hannibal Regional Healthcare System- Site Number : 8400035, Hannibal
  • Washington University- Site Number : 8400144, St Louis
RekryterarFas 3
Ålder 40 till 80 · Alla kön · Uppdaterad 1 okt. 2026 · NCT07190222

Nebulizer Versus Handheld Maintenance Therapy for Patients With COPD

  • Midwest Chest Consultants, P.C., Saint Charles
RekryterarFas 4
Ålder 60 och äldre · Alla kön · Uppdaterad 14 sep. 2026 · NCT07816835

A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease

  • Research Site, Chesterfield
  • Research Site, Hannibal
  • Research Site, St Louis
  • och 1 fler
RekryterarFas 2
Ålder 40 och äldre · Alla kön · Uppdaterad 9 sep. 2026 · NCT07082738

A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)

  • Research Site, Hannibal
RekryterarFas 3
Ålder 40 till 80 · Alla kön · Uppdaterad 3 sep. 2026 · NCT06878261

A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)

  • Research Site, St Louis
RekryterarFas 3
Ålder 40 till 80 · Alla kön · Uppdaterad 3 sep. 2026 · NCT06883305

A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease

  • Washington University School of Medicine, St Louis
  • Barnes-Jewish Hospital Investigational Drug Service, St Louis
  • Barnes-Jewish Hospital, St Louis
  • och 2 fler
RekryterarFas 2/3
Ålder 35 till 80 · Alla kön · Uppdaterad 31 aug. 2026 · NCT07363694

Från ClinicalTrials.gov, data hämtad 3 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.